AR006216A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES

Info

Publication number
AR006216A1
AR006216A1 ARP970101003A ARP970101003A AR006216A1 AR 006216 A1 AR006216 A1 AR 006216A1 AR P970101003 A ARP970101003 A AR P970101003A AR P970101003 A ARP970101003 A AR P970101003A AR 006216 A1 AR006216 A1 AR 006216A1
Authority
AR
Argentina
Prior art keywords
medicines
sustained release
peptide salt
preparation
pharmaceutical compositions
Prior art date
Application number
ARP970101003A
Other languages
Spanish (es)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Priority to ARP970101003A priority Critical patent/AR006216A1/en
Publication of AR006216A1 publication Critical patent/AR006216A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica, no particulada, de liberación sostenida para la administración parenteral a un paciente, composición que consisteesencialmente en (1) una sal de péptido gelificable, y (2) hasta 30 por ciento por peso de unvehícu lo soluble, monomérico, farmacéuticamente aceptable,compuesta en una forma de sólido cilíndrico, en la cual la composición sólida automática forma un gel tras la interacción con los fluidos corporales delpaciente, y libera el péptido demanera cont inua dentro del paciente en el curso de un período de por lo menos tres días de duración, método para supreparación, uso de una sal de péptido gelificable para preparar medicamentos y medicamentos que los contienen.A sustained release, nonparticulate pharmaceutical composition for parenteral administration to a patient, a composition consisting essentially of (1) a gellable peptide salt, and (2) up to 30 weight percent of a soluble, monomeric, pharmaceutically acceptable vehicle , composed in a cylindrical solid form, in which the automatic solid composition forms a gel upon interaction with the patient's body fluids, and continuously releases the peptide within the patient over the course of a period of at least three days lasting, method for overcoming, use of a gellable peptide salt to prepare drugs and medicines containing them.

ARP970101003A 1997-03-13 1997-03-13 PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES AR006216A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP970101003A AR006216A1 (en) 1997-03-13 1997-03-13 PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP970101003A AR006216A1 (en) 1997-03-13 1997-03-13 PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES

Publications (1)

Publication Number Publication Date
AR006216A1 true AR006216A1 (en) 1999-08-11

Family

ID=51929462

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101003A AR006216A1 (en) 1997-03-13 1997-03-13 PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES

Country Status (1)

Country Link
AR (1) AR006216A1 (en)

Similar Documents

Publication Publication Date Title
BR9508687A (en) Sustained release of peptides from pharmaceutical compositions
ES2178430T3 (en) USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY.
RU94032150A (en) Medicinal agent exhibiting delayed release of active-acting substance
CO4340618A1 (en) PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE
BR9808888A (en) Dosage forms and method of improving male erectile dysfunction
DE3363321D1 (en) Long-lasting three layered pharmaceutical film preparations
CO4750822A1 (en) TADA PHARMACEUTICAL FORMULATIONS FOR THE ADMINISTRATION IN THE GASTROINTESTINAL TRACT AND PROCESSES TO PREPARE THE SAME
CO5261582A1 (en) VALDECOXIB COMPOSITIONS
EA200700049A1 (en) PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL
AR042977A1 (en) PALONOSETRON LIQUID PHARMACEUTICAL FORMULATIONS
CO5261492A1 (en) DOSAGE FORMS OF CONTROLLED RELEASE THAT INCLUDE ZOLPIDEM OR SALTS OF THE SAME
CR7938A (en) PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMIC ERYTHEMATE LUPUS
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
CR7936A (en) PARENTERAL FORMULATIONS OF A PEPTIDE FOR THE TREATMENT OF SITEMIC ERITEMATOSUS LUPUS
AR004391A1 (en) CONTROLLED RELEASE FORMULATION FOR BASIC PHARMACS SLIMMY SOLUBLE.
AR033688A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION
DE60327843D1 (en) MEDICAMENT FORMULATIONS WITH DELAYED RELEASE WITH A CARRIER PEPTIDE
AR036312A1 (en) PHARMACEUTICAL COMPOSITION
BR0013719A (en) Controlled-release oral dosage, suitable for oral administration
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
ES2115571T3 (en) USE OF PENTOSANA POLISULFATE FOR THE RESOLUTION OF SCARS IN CHRONIC PROGRESSIVE VASCULAR DISEASES.
CO4970695A1 (en) PHARMACEUTICAL FORMULATIONS FOR CAPTOTECINE ANALOGS IN GELATIN CAPSULE
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
AR006216A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES
KR900011461A (en) Therapeutics using trypstatin as an active ingredient

Legal Events

Date Code Title Description
FC Refusal